I have to say... your tone is quite dismissive/disrespectful. It seems weird to try and discredit me to refute an argument that I didn't make.
In fact, I made a point to say that this isn't my exact field of study, then posed the question of whether people had any experience with coincidentally being on nal and imodium simultaneously.
There was a time in my life when I would have been willing to get in to this kind of posturing to argue about a paper, but those days are long gone for me. I was just asking a simple question to try and gather data if they are out there.
Nutella wrote:
I wouldn't take a single rat paper very seriously (as a researcher you are probably aware that majority of published papers are wrong, right?).
To get back to humans: if availability of naltrexone were a limiting factor (say, by the stated mechanism of peripheral receptors competing for the drug) then one would expect a sharp dose-dependence in at least some range of concentrations. So if loperamide were to be helpful, a simple doubling of the dosage would have been felt with regard to CNS effect (if any, of course). Which does not seem to be the case - several human trials of naltrexone included different dosages and there were no obvious differences above ~ 50 mg daily. Some people do report that 100 mg seems to work better but none of it is solidly documented. I experimented with 100 mg and saw no improvement - and in every respect naltrexone has very mild effects on me. In addition, I'd guess that GI mu-opioid receptors are not a major target of naltrexone in humans. If they were, wouldn't naltrexone have significant effects on GI tract? As opposed to a very mild side effect observed among minority of users?
If you do decide to experiment, please report back. Knowledge is good but nothing beats real experiments
